BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barnett GC, Coles CE, Elliott RM, Baynes C, Luccarini C, Conroy D, Wilkinson JS, Tyrer J, Misra V, Platte R. Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study. Lancet Oncol. 2012;13:65-77. [PMID: 22169268 DOI: 10.1016/s1470-2045(11)70302-3] [Cited by in Crossref: 159] [Cited by in F6Publishing: 71] [Article Influence: 14.5] [Reference Citation Analysis]
Number Citing Articles
1 Srivastava A, Leighton X, Eidelman O, Starr J, Jozwik C, Srivastava M, Pollard HB, Singh VK. Personalized Radioproteomics: Identification of a Protein Biomarker Signature for Preemptive Rescue by Tocopherol Succinate in CD34+ Irradiated Progenitor Cells Isolated from a Healthy Control Donor. J Proteomics Bioinform 2015;8:23-30. [PMID: 27087761 DOI: 10.4172/jpb.1000349] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Song YZ, Duan MN, Zhang YY, Shi WY, Xia CC, Dong LH. ERCC2 polymorphisms and radiation-induced adverse effects on normal tissue: systematic review with meta-analysis and trial sequential analysis. Radiat Oncol 2015;10:247. [PMID: 26627042 DOI: 10.1186/s13014-015-0558-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
3 Lee S, Kerns S, Ostrer H, Rosenstein B, Deasy JO, Oh JH. Machine Learning on a Genome-wide Association Study to Predict Late Genitourinary Toxicity After Prostate Radiation Therapy. Int J Radiat Oncol Biol Phys 2018;101:128-35. [PMID: 29502932 DOI: 10.1016/j.ijrobp.2018.01.054] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 8.3] [Reference Citation Analysis]
4 Du L, Ma N, Dai X, Yu W, Huang X, Xu S, Liu F, He Q, Liu Y, Wang Q, Liu X, Zheng H, Qu B. Precise prediction of the radiation pneumonitis in lung cancer: an explorative preliminary mathematical model using genotype information. J Cancer 2020;11:2329-38. [PMID: 32127959 DOI: 10.7150/jca.37708] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Kerns SL, de Ruysscher D, Andreassen CN, Azria D, Barnett GC, Chang-Claude J, Davidson S, Deasy JO, Dunning AM, Ostrer H, Rosenstein BS, West CM, Bentzen SM. STROGAR - STrengthening the Reporting Of Genetic Association studies in Radiogenomics. Radiother Oncol 2014;110:182-8. [PMID: 23993398 DOI: 10.1016/j.radonc.2013.07.011] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 5.3] [Reference Citation Analysis]
6 Jiang M, Yang J, Li K, Liu J, Jing X, Tang M. Insights into the theranostic value of precision medicine on advanced radiotherapy to breast cancer. Int J Med Sci 2021;18:626-38. [PMID: 33437197 DOI: 10.7150/ijms.49544] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Kamran SC, Mouw KW. Applying Precision Oncology Principles in Radiation Oncology. JCO Precis Oncol 2018;2:PO. [PMID: 32914000 DOI: 10.1200/PO.18.00034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
8 Zhao J, Zhi Z, Zhang M, Li Q, Li J, Wang X, Ma C. Predictive value of single nucleotide polymorphisms in XRCC1 for radiation-induced normal tissue toxicity. Onco Targets Ther 2018;11:3901-18. [PMID: 30013370 DOI: 10.2147/OTT.S156175] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 McKay MJ, Goh SK, McKay JN, Chao M, McKay TM. Non-homologous end-joining protein expression screen from radiosensitive cancer patients yields a novel DNA double strand break repair phenotype. Ann Transl Med 2017;5:96. [PMID: 28361061 DOI: 10.21037/atm.2017.03.04] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
10 Pesapane F, Suter MB, Rotili A, Penco S, Nigro O, Cremonesi M, Bellomi M, Jereczek-Fossa BA, Pinotti G, Cassano E. Will traditional biopsy be substituted by radiomics and liquid biopsy for breast cancer diagnosis and characterisation? Med Oncol 2020;37:29. [PMID: 32180032 DOI: 10.1007/s12032-020-01353-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
11 Bibault JE, Tinhofer I. The role of Next-Generation Sequencing in tumoral radiosensitivity prediction. Clin Transl Radiat Oncol 2017;3:16-20. [PMID: 29658008 DOI: 10.1016/j.ctro.2017.03.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
12 Castillo R, Pham N, Castillo E, Aso-Gonzalez S, Ansari S, Hobbs B, Palacio D, Skinner H, Guerrero TM. Pre-Radiation Therapy Fluorine 18 Fluorodeoxyglucose PET Helps Identify Patients with Esophageal Cancer at High Risk for Radiation Pneumonitis. Radiology 2015;275:822-31. [PMID: 25584706 DOI: 10.1148/radiol.14140457] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
13 Grade M, Wolff HA, Gaedcke J, Ghadimi BM. The molecular basis of chemoradiosensitivity in rectal cancer: implications for personalized therapies. Langenbecks Arch Surg 2012;397:543-55. [PMID: 22382702 DOI: 10.1007/s00423-012-0929-5] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
14 Wong P, Han K. Lack of toxicity in a patient with germline TP53 mutation treated with radiotherapy. Curr Oncol 2014;21:e349-53. [PMID: 24764719 DOI: 10.3747/co.21.1841] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
15 Margalit DN, Jordahl KM, Werner L, Wang X, Gwo-Shu Lee M, Penney KL, Batista JL, Martin NE, Chan JM, Kantoff PW, Stampfer MJ, Nguyen PL, Mucci LA. GermLine Variation in Superoxide Dismutase-2 (SOD2) and Survival Outcomes After Radiation Therapy for Prostate Cancer: Results of a Test and Validation Set Analysis. Clin Genitourin Cancer 2015;13:370-377.e1. [PMID: 25662905 DOI: 10.1016/j.clgc.2014.12.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
16 Alsbeih G, El-Sebaie M, Al-Harbi N, Al-Hadyan K, Shoukri M, Al-Rajhi N. SNPs in genes implicated in radiation response are associated with radiotoxicity and evoke roles as predictive and prognostic biomarkers. Radiat Oncol 2013;8:125. [PMID: 23697595 DOI: 10.1186/1748-717X-8-125] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
17 Xu L, Osei B, Osei E. A review of radiation genomics: integrating patient radiation response with genomics for personalised and targeted radiation therapy. J Radiother Pract 2019;18:198-209. [DOI: 10.1017/s1460396918000547] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Unger K. Integrative radiation systems biology. Radiat Oncol 2014;9:21. [PMID: 24411063 DOI: 10.1186/1748-717X-9-21] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
19 Kazemzadeh A, Abedi I, Amouheidari A, Shirvany A. A radiobiological comparison of hypo-fractionation versus conventional fractionation for breast cancer 3D-conformal radiation therapy. Rep Pract Oncol Radiother 2021;26:86-92. [PMID: 34046218 DOI: 10.5603/RPOR.a2021.0015] [Reference Citation Analysis]
20 Teo MTW, Dyrskjøt L, Nsengimana J, Buchwald C, Snowden H, Morgan J, Jensen JB, Knowles MA, Taylor G, Barrett JH, Borre M, Ørntoft TF, Bishop DT, Kiltie AE. Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer. Ann Oncol 2014;25:877-83. [PMID: 24623370 DOI: 10.1093/annonc/mdu014] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
21 Herskind C, Talbot CJ, Kerns SL, Veldwijk MR, Rosenstein BS, West CM. Radiogenomics: A systems biology approach to understanding genetic risk factors for radiotherapy toxicity? Cancer Lett 2016;382:95-109. [PMID: 26944314 DOI: 10.1016/j.canlet.2016.02.035] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 7.7] [Reference Citation Analysis]
22 Giammarile F, Muylle K, Delgado Bolton R, Kunikowska J, Haberkorn U, Oyen W. Dosimetry in clinical radionuclide therapy: the devil is in the detail. Eur J Nucl Med Mol Imaging 2017;44:2137-9. [PMID: 28891040 DOI: 10.1007/s00259-017-3820-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 5.2] [Reference Citation Analysis]
23 Sumner W, Ray X, Sutton L, Rebibo D, Marincola F, Sanghvi P, Moiseenko V, Deichaite I. Gene alterations as predictors of radiation-induced toxicity in head and neck squamous cell carcinoma. J Transl Med 2021;19:212. [PMID: 34001187 DOI: 10.1186/s12967-021-02876-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Kerns SL, Ostrer H, Rosenstein BS. Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy. Cancer Discov 2014;4:155-65. [PMID: 24441285 DOI: 10.1158/2159-8290.CD-13-0197] [Cited by in Crossref: 70] [Cited by in F6Publishing: 33] [Article Influence: 8.8] [Reference Citation Analysis]
25 Vogelius IR, Petersen J, Bentzen SM. Harnessing data science to advance radiation oncology. Mol Oncol 2020;14:1514-28. [PMID: 32255249 DOI: 10.1002/1878-0261.12685] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
26 Aguado-Barrera ME, Martínez-Calvo L, Fernández-Tajes J, Calvo-Crespo P, Taboada-Valladares B, Lobato-Busto R, Gómez-Caamaño A, Vega A. Validation of Polymorphisms Associated with the Risk of Radiation-Induced Oesophagitis in an Independent Cohort of Non-Small-Cell Lung Cancer Patients. Cancers (Basel) 2021;13:1447. [PMID: 33810047 DOI: 10.3390/cancers13061447] [Reference Citation Analysis]
27 Massi MC, Gasperoni F, Ieva F, Paganoni AM, Zunino P, Manzoni A, Franco NR, Veldeman L, Ost P, Fonteyne V, Talbot CJ, Rattay T, Webb A, Symonds PR, Johnson K, Lambrecht M, Haustermans K, De Meerleer G, de Ruysscher D, Vanneste B, Van Limbergen E, Choudhury A, Elliott RM, Sperk E, Herskind C, Veldwijk MR, Avuzzi B, Giandini T, Valdagni R, Cicchetti A, Azria D, Jacquet MF, Rosenstein BS, Stock RG, Collado K, Vega A, Aguado-Barrera ME, Calvo P, Dunning AM, Fachal L, Kerns SL, Payne D, Chang-Claude J, Seibold P, West CML, Rancati T. A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort. Front Oncol 2020;10:541281. [PMID: 33178576 DOI: 10.3389/fonc.2020.541281] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
28 Rosenstein BS, West CM, Bentzen SM, Alsner J, Andreassen CN, Azria D, Barnett GC, Baumann M, Burnet N, Chang-Claude J, Chuang EY, Coles CE, Dekker A, De Ruyck K, De Ruysscher D, Drumea K, Dunning AM, Easton D, Eeles R, Fachal L, Gutiérrez-Enríquez S, Haustermans K, Henríquez-Hernández LA, Imai T, Jones GD, Kerns SL, Liao Z, Onel K, Ostrer H, Parliament M, Pharoah PD, Rebbeck TR, Talbot CJ, Thierens H, Vega A, Witte JS, Wong P, Zenhausern F; Radiogenomics Consortium. Radiogenomics: radiobiology enters the era of big data and team science. Int J Radiat Oncol Biol Phys 2014;89:709-13. [PMID: 24969789 DOI: 10.1016/j.ijrobp.2014.03.009] [Cited by in Crossref: 73] [Cited by in F6Publishing: 60] [Article Influence: 9.1] [Reference Citation Analysis]
29 Cheuk IW, Yip SP, Kwong DL, Wu VW. Association of XRCC1 and XRCC3 gene haplotypes with the development of radiation-induced fibrosis in patients with nasopharyngeal carcinoma. Mol Clin Oncol 2014;2:553-8. [PMID: 24940494 DOI: 10.3892/mco.2014.276] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
30 Caudell JJ, Torres-Roca JF, Gillies RJ, Enderling H, Kim S, Rishi A, Moros EG, Harrison LB. The future of personalised radiotherapy for head and neck cancer. Lancet Oncol 2017;18:e266-73. [PMID: 28456586 DOI: 10.1016/S1470-2045(17)30252-8] [Cited by in Crossref: 85] [Cited by in F6Publishing: 40] [Article Influence: 17.0] [Reference Citation Analysis]
31 Kelsey CR, Jackson IL, Langdon S, Owzar K, Hubbs J, Vujaskovic Z, Das S, Marks LB. Analysis of single nucleotide polymorphisms and radiation sensitivity of the lung assessed with an objective radiologic endpoin. Clin Lung Cancer 2013;14:267-74. [PMID: 23313170 DOI: 10.1016/j.cllc.2012.10.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
32 Kerns SL, Dorling L, Fachal L, Bentzen S, Pharoah PD, Barnes DR, Gómez-Caamaño A, Carballo AM, Dearnaley DP, Peleteiro P, Gulliford SL, Hall E, Michailidou K, Carracedo Á, Sia M, Stock R, Stone NN, Sydes MR, Tyrer JP, Ahmed S, Parliament M, Ostrer H, Rosenstein BS, Vega A, Burnet NG, Dunning AM, Barnett GC, West CM; Radiogenomics Consortium. Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer. EBioMedicine 2016;10:150-63. [PMID: 27515689 DOI: 10.1016/j.ebiom.2016.07.022] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 8.3] [Reference Citation Analysis]
33 Modiri A, Vogelius I, Rechner LA, Nygård L, Bentzen SM, Specht L. Outcome-based multiobjective optimization of lymphoma radiation therapy plans. Br J Radiol 2021;94:20210303. [PMID: 34541859 DOI: 10.1259/bjr.20210303] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Lacombe J, Riou O, Solassol J, Mangé A, Bourgier C, Fenoglietto P, Pèlegrin A, Ozsahin M, Azria D. [Intrinsic radiosensitivity: predictive assays that will change daily practice]. Cancer Radiother 2013;17:337-43. [PMID: 23999252 DOI: 10.1016/j.canrad.2013.07.137] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
35 Zhang Y, Liu Z, Wang M, Tian H, Su K, Cui J, Dong L, Han F. Single Nucleotide Polymorphism rs1801516 in Ataxia Telangiectasia-Mutated Gene Predicts Late Fibrosis in Cancer Patients After Radiotherapy: A PRISMA-Compliant Systematic Review and Meta-Analysis. Medicine (Baltimore) 2016;95:e3267. [PMID: 27057881 DOI: 10.1097/MD.0000000000003267] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
36 Liu JC, Shen WC, Shih TC, Tsai CW, Chang WS, Cho Y, Tsai CH, Bau DT. The current progress and future prospects of personalized radiogenomic cancer study. Biomedicine (Taipei) 2015;5:2. [PMID: 25705582 DOI: 10.7603/s40681-015-0002-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
37 Du L, Yu W, Huang X, Zhao N, Liu F, Tong F, Zhang S, Niu B, Liu X, Xu S, Huang Y, Dai X, Xie C, Chen G, Cong X, Qu B. GSTP1 Ile105Val polymorphism might be associated with the risk of radiation pneumonitis among lung cancer patients in Chinese population: A prospective study. J Cancer 2018;9:726-35. [PMID: 29556330 DOI: 10.7150/jca.20643] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
38 Guhlich M, Hubert L, Mergler CPN, Rave-Fraenk M, Dröge LH, Leu M, Schmidberger H, Rieken S, Hille A, Schirmer MA. Identification of Risk Loci for Radiotoxicity in Prostate Cancer by Comprehensive Genotyping of TGFB1 and TGFBR1. Cancers (Basel) 2021;13:5585. [PMID: 34771749 DOI: 10.3390/cancers13215585] [Reference Citation Analysis]
39 Karg O. [Interprofessional collaboration of physicians and respiratory therapists : It is easier as a team]. Med Klin Intensivmed Notfmed 2017;112:62-3. [PMID: 28011987 DOI: 10.1007/s00063-016-0250-0] [Reference Citation Analysis]
40 Takenaka M, Hosono M, Hayashi S, Nishida T, Kudo M. The radiation doses and radiation protection on the endoscopic retrograde cholangiopancreatography procedures. Br J Radiol 2021;94:20210399. [PMID: 34379457 DOI: 10.1259/bjr.20210399] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Zhao Y, Wang X, Jiang X, Ohno-Machado L, Tang H. Choosing blindly but wisely: differentially private solicitation of DNA datasets for disease marker discovery. J Am Med Inform Assoc 2015;22:100-8. [PMID: 25352565 DOI: 10.1136/amiajnl-2014-003043] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
42 Fachal L, Gómez-Caamaño A, Barnett GC, Peleteiro P, Carballo AM, Calvo-Crespo P, Kerns SL, Sánchez-García M, Lobato-Busto R, Dorling L, Elliott RM, Dearnaley DP, Sydes MR, Hall E, Burnet NG, Carracedo Á, Rosenstein BS, West CM, Dunning AM, Vega A. A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1. Nat Genet 2014;46:891-4. [PMID: 24974847 DOI: 10.1038/ng.3020] [Cited by in Crossref: 93] [Cited by in F6Publishing: 89] [Article Influence: 11.6] [Reference Citation Analysis]
43 Estorch Cabrera M. Metabolic therapy and internal dosimetry: A difficult but necessary encounter. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 2021;40:137-8. [DOI: 10.1016/j.remnie.2021.03.020] [Reference Citation Analysis]
44 Ferreira MR, Thomas K, Truelove L, Khan A, Parker C, Dearnaley DP, Gulliford S. Dosimetry and Gastrointestinal Toxicity Relationships in a Phase II Trial of Pelvic Lymph Node Radiotherapy in Advanced Localised Prostate Cancer. Clin Oncol (R Coll Radiol) 2019;31:374-84. [PMID: 30902559 DOI: 10.1016/j.clon.2019.02.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
45 Kerns SL, Stock RG, Stone NN, Blacksburg SR, Rath L, Vega A, Fachal L, Gómez-Caamaño A, De Ruysscher D, Lammering G, Parliament M, Blackshaw M, Sia M, Cesaretti J, Terk M, Hixson R, Rosenstein BS, Ostrer H. Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer. Radiother Oncol 2013;107:372-6. [PMID: 23719583 DOI: 10.1016/j.radonc.2013.05.001] [Cited by in Crossref: 62] [Cited by in F6Publishing: 53] [Article Influence: 6.9] [Reference Citation Analysis]
46 Henríquez-Hernández LA, Valenciano A, Foro-Arnalot P, Alvarez-Cubero MJ, Cozar JM, Suárez-Novo JF, Castells-Esteve M, Ayala-Gil A, Fernández-Gonzalo P, Ferrer M, Guedea F, Sancho-Pardo G, Craven-Bartle J, Ortiz-Gordillo MJ, Cabrera-Roldán P, Herrera-Ramos E, Lara PC. Polymorphisms in DNA-repair genes in a cohort of prostate cancer patients from different areas in Spain: heterogeneity between populations as a confounding factor in association studies. PLoS One 2013;8:e69735. [PMID: 23936089 DOI: 10.1371/journal.pone.0069735] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
47 Lambin P, van Stiphout RG, Starmans MH, Rios-Velazquez E, Nalbantov G, Aerts HJ, Roelofs E, van Elmpt W, Boutros PC, Granone P, Valentini V, Begg AC, De Ruysscher D, Dekker A. Predicting outcomes in radiation oncology--multifactorial decision support systems. Nat Rev Clin Oncol 2013;10:27-40. [PMID: 23165123 DOI: 10.1038/nrclinonc.2012.196] [Cited by in Crossref: 250] [Cited by in F6Publishing: 231] [Article Influence: 25.0] [Reference Citation Analysis]
48 Qin Q, Huang Q, Zhong Q, Fan X, Chen D, Wang L. Clinical risk factors for late intestinal toxicity after radiotherapy: a systematic review protocol. Syst Rev 2013;2:39. [PMID: 23759030 DOI: 10.1186/2046-4053-2-39] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
49 Haston CK. Mouse genetic approaches applied to the normal tissue radiation response. Front Oncol 2012;2:94. [PMID: 22891164 DOI: 10.3389/fonc.2012.00094] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
50 Durante M. New challenges in high-energy particle radiobiology. Br J Radiol 2014;87:20130626. [PMID: 24198199 DOI: 10.1259/bjr.20130626] [Cited by in Crossref: 85] [Cited by in F6Publishing: 72] [Article Influence: 10.6] [Reference Citation Analysis]
51 Ahmad I. Occupational radiation dose limits: Towards breaking the one-size-fits-all paradigm. Phys Med 2018;55:155-6. [PMID: 30340846 DOI: 10.1016/j.ejmp.2018.10.008] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
52 Zanusso C, Bortolus R, Dreussi E, Polesel J, Montico M, Cecchin E, Gagno S, Rizzolio F, Arcicasa M, Novara G, Toffoli G. Impact of DNA repair gene polymorphisms on the risk of biochemical recurrence after radiotherapy and overall survival in prostate cancer. Oncotarget 2017;8:22863-75. [PMID: 28206966 DOI: 10.18632/oncotarget.15282] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
53 Andreassen CN, Rosenstein BS, Kerns SL, Ostrer H, De Ruysscher D, Cesaretti JA, Barnett GC, Dunning AM, Dorling L, West CML, Burnet NG, Elliott R, Coles C, Hall E, Fachal L, Vega A, Gómez-Caamaño A, Talbot CJ, Symonds RP, De Ruyck K, Thierens H, Ost P, Chang-Claude J, Seibold P, Popanda O, Overgaard M, Dearnaley D, Sydes MR, Azria D, Koch CA, Parliament M, Blackshaw M, Sia M, Fuentes-Raspall MJ, Ramon Y Cajal T, Barnadas A, Vesprini D, Gutiérrez-Enríquez S, Mollà M, Díez O, Yarnold JR, Overgaard J, Bentzen SM, Alsner J; International Radiogenomics Consortium (RgC). Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients. Radiother Oncol 2016;121:431-9. [PMID: 27443449 DOI: 10.1016/j.radonc.2016.06.017] [Cited by in Crossref: 64] [Cited by in F6Publishing: 51] [Article Influence: 10.7] [Reference Citation Analysis]
54 Scaife JE, Barnett GC, Noble DJ, Jena R, Thomas SJ, West CM, Burnet NG. Exploiting biological and physical determinants of radiotherapy toxicity to individualize treatment. Br J Radiol. 2015;88:20150172. [PMID: 26084351 DOI: 10.1259/bjr.20150172] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
55 Rosenstein BS. Radiogenomics: Identification of Genomic Predictors for Radiation Toxicity. Semin Radiat Oncol 2017;27:300-9. [PMID: 28865512 DOI: 10.1016/j.semradonc.2017.04.005] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
56 Orth M, Lauber K, Niyazi M, Friedl AA, Li M, Maihöfer C, Schüttrumpf L, Ernst A, Niemöller OM, Belka C. Current concepts in clinical radiation oncology. Radiat Environ Biophys 2014;53:1-29. [PMID: 24141602 DOI: 10.1007/s00411-013-0497-2] [Cited by in Crossref: 92] [Cited by in F6Publishing: 86] [Article Influence: 10.2] [Reference Citation Analysis]
57 Tinganelli W, Durante M. Carbon Ion Radiobiology. Cancers (Basel) 2020;12:E3022. [PMID: 33080914 DOI: 10.3390/cancers12103022] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
58 van Rossum AGJ, Kok M, McCool D, Opdam M, Miltenburg NC, Mandjes IAM, van Leeuwen-Stok E, Imholz ALT, Portielje JEA, Bos MMEM, van Bochove A, van Werkhoven E, Schmidt MK, Oosterkamp HM, Linn SC. Independent replication of polymorphisms predicting toxicity in breast cancer patients randomized between dose-dense and docetaxel-containing adjuvant chemotherapy. Oncotarget 2017;8:113531-42. [PMID: 29371927 DOI: 10.18632/oncotarget.22697] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
59 Su Y, Zhang Y, Sun M, Liu W, Pei F, Han F. Association between NF-κB Activation in Peripheral Blood Mononuclear Cells and Late Skin and Subcutaneous Fibrosis following Radiotherapy. Biomed Res Int 2020;2020:2957818. [PMID: 32775415 DOI: 10.1155/2020/2957818] [Reference Citation Analysis]
60 Marinko T, Stojanov Konda JT, Dolžan V, Goričar K. Genetic Variability of Antioxidative Mechanisms and Cardiotoxicity after Adjuvant Radiotherapy in HER2-Positive Breast Cancer Patients. Dis Markers 2020;2020:6645588. [PMID: 33425072 DOI: 10.1155/2020/6645588] [Reference Citation Analysis]
61 Deneuve S, Mirjolet C, Bastogne T, Duclos M, Retif P, Zrounba P, Roux PE, Poupart M, Vogin G, Foray N, Pereira S. Proof of Concept of a Binary Blood Assay for Predicting Radiosensitivity. Cancers (Basel) 2021;13:2477. [PMID: 34069662 DOI: 10.3390/cancers13102477] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Alsbeih G, El-Sebaie M, Al-Rajhi N, Al-Harbi N, Al-Hadyan K, Al-Qahtani S, Alsubael M, Al-Shabanah M, Moftah B. Among 45 variants in 11 genes, HDM2 promoter polymorphisms emerge as new candidate biomarker associated with radiation toxicity. 3 Biotech 2014;4:137-48. [PMID: 28324443 DOI: 10.1007/s13205-013-0135-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
63 Petereit DG, Hahn LJ, Kanekar S, Boylan A, Bentzen SM, Ritter M, Moser AR. Prevalence of ATM Sequence Variants in Northern Plains American Indian Cancer Patients. Front Oncol 2013;3:318. [PMID: 24416720 DOI: 10.3389/fonc.2013.00318] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
64 Song YZ, Han FJ, Liu M, Xia CC, Shi WY, Dong LH. Association between Single Nucleotide Polymorphisms in XRCC3 and Radiation-Induced Adverse Effects on Normal Tissue: A Meta-Analysis. PLoS One 2015;10:e0130388. [PMID: 26091483 DOI: 10.1371/journal.pone.0130388] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
65 Barnett GC, Elliott RM, Alsner J, Andreassen CN, Abdelhay O, Burnet NG, Chang-Claude J, Coles CE, Gutiérrez-Enríquez S, Fuentes-Raspall MJ, Alonso-Muñoz MC, Kerns S, Raabe A, Symonds RP, Seibold P, Talbot CJ, Wenz F, Wilkinson J, Yarnold J, Dunning AM, Rosenstein BS, West CM, Bentzen SM. Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity. Radiother Oncol 2012;105:289-95. [PMID: 23199655 DOI: 10.1016/j.radonc.2012.10.017] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 5.2] [Reference Citation Analysis]
66 Ahmed M, Dorling L, Kerns S, Fachal L, Elliott R, Partliament M, Rosenstein BS, Vega A, Gómez-Caamaño A, Barnett G, Dearnaley DP, Hall E, Sydes M, Burnet N, Pharoah PD, Eeles R, West CM. Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity. Br J Cancer 2016;114:1165-74. [PMID: 27070714 DOI: 10.1038/bjc.2016.94] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
67 Henríquez-Hernández LA, Valenciano A, Foro-Arnalot P, Álvarez-Cubero MJ, Cozar JM, Suárez-Novo JF, Castells-Esteve M, Fernández-Gonzalo P, De-Paula-Carranza B, Ferrer M, Guedea F, Sancho-Pardo G, Craven-Bartle J, Ortiz-Gordillo MJ, Cabrera-Roldán P, Herrera-Ramos E, Rodríguez-Gallego C, Rodríguez-Melcón JI, Lara PC. Single nucleotide polymorphisms in DNA repair genes as risk factors associated to prostate cancer progression. BMC Med Genet 2014;15:143. [PMID: 25540025 DOI: 10.1186/s12881-014-0143-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
68 Showalter TN, Wages NA, Ohri N. Strategic evaluation of interventions to prevent consequential late proctitis after prostate radiation therapy: new clinical trial designs should be considered. Cancer Biol Ther 2014;15:361-4. [PMID: 24521697 DOI: 10.4161/cbt.27822] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
69 Manning G, Rothkamm K. Deoxyribonucleic acid damage-associated biomarkers of ionising radiation: current status and future relevance for radiology and radiotherapy. Br J Radiol. 2013;86:20130173. [PMID: 23659923 DOI: 10.1259/bjr.20130173] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
70 Grossberg AJ, Lei X, Xu T, Shaitelman SF, Hoffman KE, Bloom ES, Stauder MC, Tereffe W, Schlembach PJ, Woodward WA, Buchholz TA, Smith BD. Association of Transforming Growth Factor β Polymorphism C-509T With Radiation-Induced Fibrosis Among Patients With Early-Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial. JAMA Oncol 2018;4:1751-7. [PMID: 30027292 DOI: 10.1001/jamaoncol.2018.2583] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
71 Zhao Y, Yang L, Wu D, He H, Wang M, Ge T, Liu Y, Tian H, Cui J, Jia L, Wan Z, Han F. Gene-environment interaction for polymorphisms in ataxia telangiectasia-mutated gene and radiation exposure in carcinogenesis: results from two literature-based meta-analyses of 27120 participants. Oncotarget 2016;7:76867-81. [PMID: 27764772 DOI: 10.18632/oncotarget.12724] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
72 Patrono C, Sterpone S, Testa A, Cozzi R. Polymorphisms in base excision repair genes: Breast cancer risk and individual radiosensitivity. World J Clin Oncol 2014; 5(5): 874-882 [PMID: 25493225 DOI: 10.5306/wjco.v5.i5.874] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
73 Van den Broeck T, Joniau S, Clinckemalie L, Helsen C, Prekovic S, Spans L, Tosco L, Van Poppel H, Claessens F. The role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision making. Biomed Res Int 2014;2014:627510. [PMID: 24701578 DOI: 10.1155/2014/627510] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
74 Talbot CJ, Tanteles GA, Barnett GC, Burnet NG, Chang-Claude J, Coles CE, Davidson S, Dunning AM, Mills J, Murray RJ, Popanda O, Seibold P, West CM, Yarnold JR, Symonds RP. A replicated association between polymorphisms near TNFα and risk for adverse reactions to radiotherapy. Br J Cancer 2012;107:748-53. [PMID: 22767148 DOI: 10.1038/bjc.2012.290] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 5.7] [Reference Citation Analysis]
75 Valdagni R, Rancati T. Reducing rectal injury during external beam radiotherapy for prostate cancer. Nat Rev Urol 2013;10:345-57. [PMID: 23670182 DOI: 10.1038/nrurol.2013.96] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
76 Multhoff G, Trott KR. [Screening of gene polymorphisms does not improve predictability of radiation toxicity]. Strahlenther Onkol 2013;189:91-2. [PMID: 23111471 DOI: 10.1007/s00066-012-0250-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
77 Ling A, Furhang E, Ryemon SN, Ennis RD. Late small bowel toxicity after aggressive abdominopelvic intensity modulated radiation therapy. Adv Radiat Oncol 2017;2:615-23. [PMID: 29204529 DOI: 10.1016/j.adro.2017.09.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
78 Hoeben BAW, Wong JYC, Fog LS, Losert C, Filippi AR, Bentzen SM, Balduzzi A, Specht L. Total Body Irradiation in Haematopoietic Stem Cell Transplantation for Paediatric Acute Lymphoblastic Leukaemia: Review of the Literature and Future Directions. Front Pediatr 2021;9:774348. [PMID: 34926349 DOI: 10.3389/fped.2021.774348] [Reference Citation Analysis]
79 Zhu ML, Wang M, Shi TY, Li QX, Xi P, Xia KQ, Zheng L, Wei QY. No association between TGFB1 polymorphisms and late radiotherapy toxicity: a meta-analysis. PLoS One 2013;8:e76964. [PMID: 24130819 DOI: 10.1371/journal.pone.0076964] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
80 El Naqa I, Kerns SL, Coates J, Luo Y, Speers C, West CML, Rosenstein BS, Ten Haken RK. Radiogenomics and radiotherapy response modeling. Phys Med Biol 2017;62:R179-206. [PMID: 28657906 DOI: 10.1088/1361-6560/aa7c55] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 5.6] [Reference Citation Analysis]
81 Venkatesh GH, Manjunath VB, Mumbrekar KD, Negi H, Fernandes DJ, Sharan K, Banerjee S, Bola Sadashiva SR. Polymorphisms in radio-responsive genes and its association with acute toxicity among head and neck cancer patients. PLoS One 2014;9:e89079. [PMID: 24594932 DOI: 10.1371/journal.pone.0089079] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]